The global human recombinant insulin market is estimated to be valued at US$ 41602.7 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |